Malignant mesothelioma creates chaos. In the wake of an emotionally overwhelming diagnosis, patients struggle to comprehend their new reality while simultaneously being rushed into treatment to extend survival and improve the quality of their lives. The treatments are necessary whether patients opt for a curative or palliative approach, but their high price introduces financial stress to
It sounds counterintuitive, but a recent study indicates that pleural mesothelioma patients would be happier and healthier if they had fewer appointments with their physicians. The reason is simple – appointments that offer no active treatment create additional stress.
Eight months after the U.S. Food and Drug Administration approved the combination of Opdivo and Yervoy for the treatment of malignant mesothelioma, the European Union has done the same. The innovative immunotherapy protocol is now one of the most promising therapies available for treating patients whose pleural mesothelioma has been identified as unresectable.
Mesothelioma lawsuits are often contentious, adversarial proceedings, and a case pitting a Texas man’s family against 3M Company and General Dynamics is no exception. The two companies recently filed a motion to sanction the plaintiffs for having failed to conduct an autopsy after the victim’s death despite the companies’ request prior to his death that
Patients diagnosed with malignant pleural mesothelioma are faced with many difficult decisions, with the most important of all involving what medical approach should be taken to treat their disease. In the face of an aggressive terminal prognosis, many believe there’s little difference between the anticipated outcome of an aggressive approach versus a more palliative one
Though 2017 marked the highest number of mesothelioma lawsuits ever filed, noted Washington, D.C. consulting firm KCIC is reporting that since that time there has been a steady decline, and that the year 2020 marked a significant drop.
A retrospective study aimed at assessing progress and trends in mesothelioma revealed that despite the introduction of numerous innovative treatment protocols, little progress has been made in overall patient survival. It also revealed some concerning news about the growing incidence of the rare, asbestos-related disease in women.
Employees of A2 Environmental Services face significant risk of malignant mesothelioma after having been ordered to remove asbestos in an unsafe way. The safety concerns were revealed during court proceedings against the company’s owner, 45-year-old Stephanie Laskin of Newburgh, New York. Ms. Laskin pled guilty last week to illegal removal of asbestos that violated the
Despite the best efforts of researchers, malignant mesothelioma remains one of the most challenging forms of cancer to treat. There are many reasons for this, including the fact that the illness is so rare — the fewer patients there are, the less opportunity researchers have to study it and test responses. Another difficult aspect is
COVID-19 impacted many mesothelioma lawsuits, including the wrongful death claim filed by Carol Backe against Conwed Corporation. Though the trial was originally scheduled for February, its date was pushed back to May. The delay is one of many that the Backe family has faced since Gene “Randy” Backe was diagnosed with the fatal disease in